Therapeutic Targeting of Cancers with Loss of PTEN Function

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|15|1|65-79

ISSN： 1389-4501

Source： Current Drug Targets, Vol.15, Iss.1, 2014-01, pp. : 65-79

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic targeting of osteoclast function and pathways

By Broadhead Matthew L   Clark Jonathan CM   Dass Crispin R   Choong Peter FM   Myers Damian E  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 2, 2011-02 ,pp. : 169-181

Informa Healthcare

Access to resources Recommend Favorite

Metabolic Targeting of Cancers: From Molecular Mechanisms to Therapeutic Strategies

By  

Current Medicinal Chemistry, Vol. 16, Iss. 13, 2009-05 ,pp. : 1561-1587

Bentham Science Publishers

Access to resources Recommend Favorite

Post-Translational Modifications of PTEN and their Potential Therapeutic Implications

By  

Current Cancer Drug Targets, Vol. 11, Iss. 5, 2011-06 ,pp. : 536-547

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting enzymes to cancers - new developments

By Bagshawe K.D.   Burke P.J.   Knox R.J.   Melton R.G.   Sharma S.K.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 2, 1999-02 ,pp. : 161-172

Informa Healthcare

Access to resources Recommend Favorite

Targeting Basal-Like Breast Cancers

By  

Current Drug Targets, Vol. 13, Iss. 12, 2012-11 ,pp. : 1510-1524

Bentham Science Publishers

Access to resources Recommend Favorite